CALT Company Profile and Key Details
Calliditas Therapeutics AB (publ)
CALT Stock Price Chart
Stock Price Today
Calliditas Therapeutics AB (publ) (CALT) stock declined over -0.10%, trading at $40.00 on NASDAQ, down from the previous close of $40.04. The stock opened at $40.00, fluctuating between $40.00 and $43.00 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.
Company Information
| Employees | 222 |
| Beta | 1.46 |
| Sales or Revenue | $1.21B |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Calliditas Therapeutics AB (publ) (NASDAQ: CALT) stock price is $40.00 in the last trading session. During the trading session, CALT stock reached the peak price of $43.00 while $40.00 was the lowest point it dropped to. The percentage change in CALT stock occurred in the recent session was -0.1% while the dollar amount for the price change in CALT stock was -$0.04.
The NASDAQ listed CALT is part of Biotechnology industry that operates in the broader Healthcare sector. Calliditas Therapeutics AB (publ) designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Mikael Widell
Head of Communications & IR
Mr. Jonathan A. Schur
Group Gen. Counsel
Ms. Sandra Frithiof
Head of HR
Ms. Teona Johnson
Head of US Marketing
Ms. Renee Aguiar-Lucander
Chief Executive Officer
Dr. Katayoun Welin-Berger Ph.D.
Vice President of Operations
Dr. Johan Haggblad Ph.D.
Chief Scientific Officer
Mr. Andrew B. Udell B.Sc., M.B.A.
Pres of North America Commercial
Dr. Richard S. Philipson M.D.
Chief Medical Officer
Dr. Krassimir Mitchev
Head of Medical Affairs
Mr. Fredrik Johansson
Chief Financial Officer
Ms. Ann-Kristin Myde BSc
Head of Clinical Devel. & Vice President of Project Management
CALT's closing price is 162.3% higher than its 52-week low of $15.25 where as its distance from 52-week high of $43.00 is -6.98%.
Number of CALT employees currently stands at 222.
Official Website of CALT is: https://www.calliditas.se
CALT could be contacted at phone 468 411 3005 and can also be accessed through its website. CALT operates from Kungsbron 1, D5, Stockholm, 111 22, Sweden.
CALT stock volume for the day was 9.8K shares. The average number of CALT shares traded daily for last 3 months was 7.73K.
The market value of CALT currently stands at $1.08B with its latest stock price at $40.00 and 27.02M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com